Overview

Unlock the healing and transformative benefits of psychedelic therapy with this powerful, practical, evidence-based guide. If you've sought conventional treatment for depression, anxiety, substance-use disorder, or post-traumatic stress disorder (PTSD) and have been disappointed by a lack of positive results, know that you're not alone. The good news is that there is hope. More and more, research shows the tremendous benefit of psychedelic drugs like psilocybin, MDMA, LSD, and ketamine for people suffering from difficult-to-treat mental health issues. But how do you integrate them into your life effectively? In The Psychedelic Therapy Workbook, psychologists Elizabeth Nielson and Ingmar Gorman present a pioneering approach to maximizing the therapeutic potential of psychedelics. Drawing on their extensive experience and research, the authors introduce their psychedelic harm reduction and integration (PHRI) method, offering a comprehensive framework for integrating the lessons you've learned from psychedelic experiences into your daily life. With this step-by-step guide, you will: - Learn how to choose the right setting and set intentions for a positive experience - Explore evidence-based practices to ensure healing and growth - Empower yourself to navigate the psychedelic landscape with confidence and mindfulness Whether you're embarking on a therapeutic journey on your own, in a group, or with a therapist, this workbook provides the tools you need to explore the benefits of psychedelics for profound transformation, healing, and self-discovery.

Full Product Details

9781648484254

Table of Contents

Reviews

""The Psychedelic Therapy Workbook is the first book I've seen that offers a comprehensive guide for the journey, and the practitioner. These practical tools provide direction, explanations and solid advice for anyone interested in psychedelic therapy.I will need many copies of this workbook in my office to pass out to anyone and everyone ready to do this work."" --Tammy Nelson, PhD, director of the Integrative Sex Therapy Institute, and author of Open Monogamy--Tammy Nelson, PhD ""This accessible guide is an invaluable resource for both individuals and clinicians exploring the transformative potential of psychedelics. By emphasizing openness, curiosity, and embodied integration, Nielson and Gorman provide a useful pathway for those seeking to harness the potential of psychedelic experiences, while maintaining a grounded, ethical, and evidence-based perspective. Striking the right balance between scientific rigor and compassionate care, this is a must-read for those exploring psychedelics."" --Steven C. Hayes, PhD, Nevada Foundation Professor in the department of psychology at the University of Nevada, Reno; and author of A Liberated Mind--Steven C. Hayes, PhD ""This invaluable workbook is a masterful contribution at a crucial time in the psychedelic renaissance. Elizabeth Nielson and Ingmar Gorman's profound insights are grounded in their pioneering clinical research with MDMA, psilocybin, and ketamine; in their studies of the scientific literature; in their psychedelic harm reduction work; in their personal experiences; and in their work as teachers of therapists. This is an ideal textbook for a new generation."" --Rick Doblin, PhD, founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS)--Rick Doblin, PhD

Author Information

Elizabeth Nielson, PhD, is a psychologist and cofounder of Fluence with an expertise in psychedelic therapist training. She has worked on developing psychedelic therapies through conduct of FDA-approved trials of psychedelics for PTSD, substance use problems, and mood disorders, and she has published research on psychedelic therapies and psychedelic therapist training. Nielson has also worked as an educator for clinicians for over a decade and continues to create training programs to ensure the highest quality care for psychedelic users. Ingmar Gorman, PhD, is a psychologist and cofounder of Fluence, specializing in psychedelic education for mental health providers. His extensive clinical training and experience includes prestigious institutions in New York City. Notably, Gorman contributes to FDA-approved clinical trials of psychedelic treatments, and has published extensively on psychedelics and harm reduction.

Tab Content 6

Countries Available